Skip to main content

Main menu

Home
Content
Subscriptions
Authors
Info
About
More
- Alerts
- Feedback
- Help
- SNMMI Journals

SNMMI
- JNM
- JNMT
- SNMMI Journals
- SNMMI

User menu

Subscribe
My alerts
Log in
My Cart

Search

Search for this keyword

Advanced search

SNMMI
- JNM
- JNMT
- SNMMI Journals
- SNMMI

Subscribe
My alerts
Log in
My Cart

Search for this keyword

Advanced Search

Home
Content
Subscriptions
Authors
Info
About
More
- Alerts
- Feedback
- Help
- SNMMI Journals

Follow JNM on Twitter
Visit JNM on Facebook
Join JNM on LinkedIn
Subscribe to our RSS feeds

Table of Contents

May 2009; Volume 50,Issue supplement 2

The Abstract Book Supplement to the Journal of Nuclear Medicine

In this issue

Journal of Nuclear Medicine

Vol. 50, Issue supplement 2

May 2009

Table of Contents
Index by author

Search for this keyword

Sign up for alerts

Most Cited
Most Read

First-in-Human Assessment of ¹¹C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View
Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients
Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns
Is FDG maximum standardized uptake value (SUV max) of primary breast cancer can predict axillary lymph node metastasis?

© 2023 Journal of Nuclear Medicine